We only have this paper's title and publication details.
Read it at the sourceRandomized trial analysis identifies meaningful individual worsening thresholds for PRO-CTCAE toxicity scores in cancer patients, highlighting improved tracking of adverse events.
gov: NCT03249090 (AFT-39), NCT02158637 (MC1091).
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: